Kainos Medicine Inc Financial Flexibility Index
Kainos Medicine Inc financial flexibility index. Kainos Medicine Inc (284620) has a Financial Flexibility Index of -0.37x as of March 2025. Free cash flow of ₩-2.93 Billion (operating CF ₩-2.97 Billion minus capex ₩40.29 Million) represents 0% of total liabilities (₩7.97 Billion). See 284620 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Kainos Medicine Inc (2017–2024)
Financial flexibility index of Kainos Medicine Inc from 2017 to 2024. Historical Financial Flexibility Index trend for Kainos Medicine Inc across 8 annual periods. Check 284620 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Kainos Medicine Inc Financial Flexibility Index by Year (2017–2024)
Kainos Medicine Inc financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for Kainos Medicine Inc. For the full cash flow conversion analysis, see Kainos Medicine Inc (284620) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.06x | ₩-9.50 Billion | ₩-9.71 Billion | ₩8.95 Billion | ▲ +3.2% |
| 2023 | -1.10x | ₩-10.12 Billion | ₩-14.22 Billion | ₩9.23 Billion | ▼ -59.8% |
| 2022 | -0.69x | ₩-8.83 Billion | ₩-11.30 Billion | ₩12.87 Billion | ▼ -201.2% |
| 2021 | -0.23x | ₩-6.80 Billion | ₩-9.20 Billion | ₩29.85 Billion | ▲ +20.0% |
| 2020 | -0.28x | ₩-6.39 Billion | ₩-7.61 Billion | ₩22.43 Billion | ▼ -221.1% |
| 2019 | 0.24x | ₩185.74 Million | ₩185.74 Million | ₩789.89 Million | ▲ +924.8% |
| 2018 | -0.03x | ₩-22.01 Million | ₩-22.01 Million | ₩772.06 Million | ▲ +22.5% |
| 2017 | -0.04x | ₩-27.23 Million | ₩-27.23 Million | ₩740.19 Million | — |